Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2,Immunity, Inflammation and Disease

当前位置： X-MOL 学术 › Immun. Inflamm. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
Immunity, Inflammation and Disease ( IF 2.493 ) Pub Date : 2020-12-15 , DOI: 10.1002/iid3.367
Amandine Mveang Nzoghe ₁ , Paulin N. Essone _{2,

3} , Marielle Leboueny ₁ , Anicet Christel Maloupazoa Siawaya ₁ , Eliode Cyrien Bongho ₁ , Ofilia Mvoundza Ndjindji ₁ , Rotimi Myrabelle Avome Houechenou ₁ , Selidji Todagbe Agnandji _{2,

3} , Joel Fleury Djoba Siawaya ₁

Affiliation

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged throughout the world. Building knowledge around Covid‐19 is crucial to devise facts based approaches to respond efficiently against this pandemic.

中文翻译：